Finance

Lists
WOCKPHARMA:NSE
Wockhardt Ltd
₹2 009,50
+0,66%
(+13,10) 1D
12 Okt., 12:06:47 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for WOCKPHARMA...
Open
₹2 002,90
High
₹2 020,30
Low
₹1 971,60
Mkt. cap
326,53 mjd
Avg. vol.
1,23 m
Volume
474,57 k
P/E ratio
79,83
52-wk high
₹2 422,30
52-wk low
₹1 086,70
EPS
₹25,17
Shares outstanding
110,69 m
No. of employees
3 k
Open
₹2 002,90
High
₹2 020,30
Low
₹1 971,60
Mkt. cap
326,53 mjd
Avg. vol.
1,23 m
Volume
474,57 k
P/E ratio
79,83
52-wk high
₹2 422,30
52-wk low
₹1 086,70
EPS
₹25,17
Shares outstanding
110,69 m
No. of employees
3 k
News stories
From web sources and news partners
Profile
Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company has manufacturing plants in India, the UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. Wikipedia
About Wockhardt Ltd
CEOMurtaza Khorakiwala
Employees2,56 k
Founded1967
Headquarters-
SectorPharmaceutical industry
Last report
10 Aug. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
9,29 mjd / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
7,82 mjd
8,88 mjd
10,54 mjd
9,29 mjd
Cost of goods sold
2,33 mjd
3,17 mjd
4,03 mjd
3,20 mjd
Cost of revenue
2,33 mjd
3,17 mjd
4,03 mjd
3,20 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,86 mjd
1,81 mjd
1,90 mjd
2,03 mjd
Operating expense
4,42 mjd
4,63 mjd
4,19 mjd
4,76 mjd
Total operating expenses
6,75 mjd
7,80 mjd
8,22 mjd
7,96 mjd
Operating income
1,07 mjd
1,08 mjd
2,32 mjd
1,33 mjd
Other non operating income
210,00 m
250,00 m
-710,00 m
310,00 m
EBT including unusual items
910,00 m
670,00 m
1,89 mjd
1,16 mjd
EBT excluding unusual items
910,00 m
770,00 m
1,52 mjd
1,16 mjd
Income tax expense
90,00 m
60,00 m
250,00 m
90,00 m
Effective tax rate
9,89%
8,96%
13,23%
7,76%
Other operating expenses
2,03 mjd
2,17 mjd
1,76 mjd
2,18 mjd
Net income
780,00 m
590,00 m
1,66 mjd
1,06 mjd
Net profit margin
9,97%
6,64%
15,75%
11,41%
Earnings per share
-
-
-
-
Interest and investment income
-
-
70,00 m
-
Interest expense
-550,00 m
-600,00 m
-450,00 m
-520,00 m
Net interest expenses
-550,00 m
-600,00 m
-380,00 m
-520,00 m
Depreciation and amortization charges
530,00 m
650,00 m
530,00 m
550,00 m
EBITDA
1,62 mjd
1,47 mjd
2,74 mjd
1,74 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme